{"id":"https://openalex.org/W2005060187","doi":"https://doi.org/10.1128/aac.40.5.1148","title":"Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model","display_name":"Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model","alternate_titles":[],"publication_year":1996,"publication_date":"1996-05-01","ids":{"openalex":"https://openalex.org/W2005060187","doi":"https://doi.org/10.1128/aac.40.5.1148","mag":"2005060187","pmid":"https://pubmed.ncbi.nlm.nih.gov/8723456","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/163281"},"language":"en","primary_location":{"id":"doi:10.1128/aac.40.5.1148","doi":"https://doi.org/10.1128/aac.40.5.1148","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.40.5.1148","pdf_url":"https://aac.asm.org/content/aac/40/5/1148.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005060187"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/40/5/1148.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067816513","display_name":"Diane M. Cappelletty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801816960","display_name":"Detroit Receiving Hospital","ror":"https://ror.org/00682eh61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109","https://openalex.org/I2801816960"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D M Cappelletty","raw_affiliation_strings":["Department of Pharmacy Services, Detroit Receiving Hospital/University Health Center, Michigan 48201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Services, Detroit Receiving Hospital/University Health Center, Michigan 48201, USA","institution_ids":["https://openalex.org/I2801816960"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084829703","display_name":"Michael Joseph Rybak","orcid":"https://orcid.org/0000-0003-2220-0081","observed_orcids":["https://orcid.org/0000-0003-2220-0081"]},"institutions":[{"id":"https://openalex.org/I2801816960","display_name":"Detroit Receiving Hospital","ror":"https://ror.org/00682eh61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800326109","https://openalex.org/I2801816960"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M J Rybak","raw_affiliation_strings":["Department of Pharmacy Services, Detroit Receiving Hospital/University Health Center, Michigan 48201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Services, Detroit Receiving Hospital/University Health Center, Michigan 48201, USA","institution_ids":["https://openalex.org/I2801816960"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2801816960"],"apc_list":null,"apc_paid":null,"fwci":0.7696,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.70545113,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"5","first_page":"1148","last_page":"1152"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/streptococcus-pneumoniae","display_name":"Streptococcus pneumoniae","score":0.9950000047683716},{"id":"https://openalex.org/keywords/penicillin-resistance","display_name":"penicillin resistance","score":0.8960000276565552},{"id":"https://openalex.org/keywords/bactericidal-activity","display_name":"bactericidal activity","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cefprozil","display_name":"cefprozil","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cefixime","display_name":"cefixime","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cefaclor","display_name":"cefaclor","score":1.0},{"id":"https://openalex.org/keywords/loracarbef","display_name":"loracarbef","score":0.996999979019165},{"id":"https://openalex.org/keywords/antibiotic-dosing-regimens","display_name":"antibiotic dosing regimens","score":0.5389999747276306},{"id":"https://openalex.org/keywords/resistant-subpopulations","display_name":"resistant subpopulations","score":0.6610000133514404},{"id":"https://openalex.org/keywords/autolysis","display_name":"autolysis","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2778243283","wikidata":"https://www.wikidata.org/wiki/Q163901","display_name":"Cefixime","level":4,"score":0.8641623258590698},{"id":"https://openalex.org/C2779766023","wikidata":"https://www.wikidata.org/wiki/Q415167","display_name":"Cefaclor","level":4,"score":0.844403862953186},{"id":"https://openalex.org/C174802600","wikidata":"https://www.wikidata.org/wiki/Q12190","display_name":"Penicillin","level":3,"score":0.774531364440918},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7320047616958618},{"id":"https://openalex.org/C2781253189","wikidata":"https://www.wikidata.org/wiki/Q221179","display_name":"Streptococcus pneumoniae","level":3,"score":0.6769957542419434},{"id":"https://openalex.org/C2776905138","wikidata":"https://www.wikidata.org/wiki/Q1453445","display_name":"Cefdinir","level":4,"score":0.4944610595703125},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.43384796380996704},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.42019665241241455},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.40852469205856323},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38191741704940796},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.3736345171928406},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3228939175605774},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23428666591644287},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.12204009294509888}],"mesh":[{"descriptor_ui":"D000097670","descriptor_name":"Cefprozil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002433","descriptor_name":"Cefaclor","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002433","descriptor_name":"Cefaclor","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003114","descriptor_name":"Colony-Forming Units Assay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010403","descriptor_name":"Penicillin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010406","descriptor_name":"Penicillins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013296","descriptor_name":"Streptococcus pneumoniae","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D013296","descriptor_name":"Streptococcus pneumoniae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013296","descriptor_name":"Streptococcus pneumoniae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020682","descriptor_name":"Cefixime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1128/aac.40.5.1148","doi":"https://doi.org/10.1128/aac.40.5.1148","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.40.5.1148","pdf_url":"https://aac.asm.org/content/aac/40/5/1148.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:148936","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC163281","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:163281","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC163281/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:8723456","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8723456","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.612.5124","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.612.5124","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aac.asm.org/content/40/5/1148.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1128/aac.40.5.1148","doi":"https://doi.org/10.1128/aac.40.5.1148","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.40.5.1148","pdf_url":"https://aac.asm.org/content/aac/40/5/1148.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005060187.pdf","grobid_xml":"https://content.openalex.org/works/W2005060187.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1484236704","https://openalex.org/W1970620147","https://openalex.org/W1979485641","https://openalex.org/W2004346529","https://openalex.org/W2017812487","https://openalex.org/W2019789799","https://openalex.org/W2027476996","https://openalex.org/W2044008137","https://openalex.org/W2051039256","https://openalex.org/W2083565720","https://openalex.org/W2091992933","https://openalex.org/W2108344148","https://openalex.org/W2139695652"],"related_works":["https://openalex.org/W2018125691","https://openalex.org/W2141449650","https://openalex.org/W2134887175","https://openalex.org/W2036528898","https://openalex.org/W2046339266","https://openalex.org/W2108570085","https://openalex.org/W2111353697","https://openalex.org/W2106627363","https://openalex.org/W2152613918"],"abstract_inverted_index":{"We":[0],"examined":[1],"the":[2,42,67,162,177,180,184,187,213,229,274,292,301,329,360,367],"bactericidal":[3],"activities":[4],"of":[5,16,44,53,77,117,172,226,244,251,270,273,291,323,328,335,363,369],"penicillin,":[6,124,218,262,310],"cefprozil,":[7,101,219,263,309],"cefixime,":[8,109],"cefaclor,":[9,87,125],"and":[10,24,51,62,84,91,98,105,108,112,126,132,147,153,198,201,220,249,264,311,318],"loracarbef":[11],"against":[12,279,316,338,355],"three":[13],"clinical":[14],"isolates":[15,322],"Streptococcus":[17],"pneumoniae":[18,371],"which":[19,165],"were":[20,56,70,120,139,222,266],"susceptible,":[21,23],"moderately":[22],"resistant":[25,54,231],"to":[26,37,168,176,189,236,242,333],"penicillin.":[27],"An":[28],"in":[29,41,48,66,179,212,224,268,300,342,350],"vitro":[30,343],"two-compartment":[31],"glass":[32],"infection":[33,181],"model":[34,344],"was":[35,166,192,234,286,295],"used":[36],"simulate":[38],"human":[39],"pharmacokinetics":[40],"presence":[43],"bacteria.":[45],"Also,":[46],"changes":[47],"organism":[49],"susceptibility":[50],"development":[52],"subpopulations":[55],"evaluated.":[57],"Simulated":[58],"pediatric":[59],"dosage":[60],"regimens":[61,239,275],"target":[63],"peak":[64],"concentrations":[65],"central":[68],"compartment":[69],"as":[71],"follows:":[72],"penicillin":[73,196],"V-potassium,":[74],"26":[75],"mg/kg":[76,89,96,103],"body":[78],"weight":[79],"every":[80],"6":[81],"h":[82,122,129,134,217,255,261],"(q6h)":[83],"14":[85],"micrograms/ml;":[86,93,100,107],"13.4":[88],"q8h":[90],"16":[92],"loracarbef,":[94],"15":[95,102],"q12h":[97,104],"19":[99],"11":[106],"8mg/kg":[110],"q24h":[111],"4":[113],"micrograms/ml.":[114],"Targeted":[115],"half-lives":[116],"each":[118],"agent":[119],"1":[121,154],"for":[123,130,135],"loracarbef;":[127],"1.3":[128],"cefprozil;":[131],"3.5":[133,152],"cefixime.":[136],"Growth":[137],"controls":[138],"performed":[140],"at":[141,161,253],"two":[142],"different":[143],"pump":[144],"rates,":[145],"0.8":[146],"2.0":[148],"ml/min":[149],"(half-lives":[150],"=":[151],"h,":[155],"respectively).":[156],"Each":[157],"isolate":[158],"demonstrated":[159],"autolysis":[160],"lower":[163],"rate":[164,243],"attributed":[167],"a":[169,209],"decreased":[170],"supply":[171,362],"fresh":[173,364],"nutrients":[174],"available":[175],"organisms":[178],"compartment.":[182],"Against":[183,228],"susceptible":[185],"isolate,":[186,232],"time":[188],"99.9%":[190,210,284],"killing":[191,245,252],"statistically":[193],"significant":[194],"between":[195],"V-potassium":[197],"both":[199],"cefaclor":[200,221,265,312],"cefixime":[202],"(P":[203,246,256],"<":[204,247,257],"0.029).":[205],"Loracarbef":[206],"never":[207,287],"achieved":[208],"reduction":[211],"inoculum.":[214],"At":[215,259],"48":[216,260],"equivalent":[223,267],"extent":[225,250,269],"killing.":[227,271],"intermediately":[230,320],"cefprozil":[233],"superior":[235],"all":[237],"other":[238,352],"with":[240,289,372],"respect":[241],"0.013)":[248],"24":[254],"0.0003).":[258],"All":[272],"exhibited":[276],"inferior":[277],"activity":[278],"this":[280,356],"penicillin-resistant":[281,339],"isolate.":[282],"A":[283],"kill":[285],"obtained":[288],"any":[290,336],"regimens,":[293],"nor":[294],"there":[296],"an":[297,347],"appreciable":[298],"decrease":[299],"colony":[302],"counts.":[303],"In":[304],"conclusion,":[305],"it":[306],"appears":[307],"that":[308],"are":[313],"effective":[314,348],"therapies":[315,331,354],"sensitive":[317,321],"even":[319],"S.":[324,370],"pneumoniae.":[325],"However,":[326],"none":[327],"oral":[330],"appear":[332],"be":[334,346],"benefit":[337],"isolates.":[340],"The":[341],"may":[345],"tool":[349],"evaluating":[351],"multiple-dose":[353],"fastidious":[357],"organism,":[358],"since":[359],"continual":[361],"medium":[365],"maintains":[366],"viability":[368],"minimal":[373],"stationary-phase":[374],"autolysis.":[375]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005060187","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
